Outcomes of Open Versus Robotic-assisted Laparoscopic Posterior Component Separation in Complex Abdominal Wall Repair
EUROTAR
1 other identifier
observational
169
2 countries
2
Brief Summary
This is a retrospective European multicenter study evaluating surgical treatment of patients with a complex ventral incisional hernia using robotic-assisted laparoscopic transversus abdominis release (rTAR) or open transversus abdominis release (oTAR).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2021
CompletedFirst Submitted
Initial submission to the registry
December 29, 2021
CompletedFirst Posted
Study publicly available on registry
January 19, 2022
CompletedJanuary 19, 2022
January 1, 2022
10 months
December 29, 2021
January 13, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Length of postoperative hospital stay
Postoperative treatment and follow-up period in hospital
immediately after the surgery
Secondary Outcomes (2)
Complication rates
through study completion, an average of 1 year
Recurrence and reoperation rates
through study completion, an average of 2 year
Study Arms (2)
rTAR
All consecutive patients undergoing bilateral robotic transversus abdominis release operation in the treatment of their ventral incisional hernia, are considered eligible for inclusion.
oTAR
All consecutive patients undergoing bilateral open transversus abdominis release operation in the treatment of their ventral incisional hernia, are considered eligible for inclusion.
Interventions
Mini-invasive robotic-assisted TAR using either DaVinci Xi or Si systems and 6 laparoscopic ports.
Eligibility Criteria
Consecutive patients undergoing bilateral either open of robotic-assisted transversus abdominis release in the treatment of their ventral incisional hernia.
You may qualify if:
- All consecutive patients undergoing bilateral either open of robotic-assisted transversus abdominis release in the treatment of their ventral incisional hernia.
You may not qualify if:
- unilateral transversus abdominis release
- patients with a stoma or parastomal hernia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oululead
- Algemeen Ziekenhuis Maria Middelarescollaborator
Study Sites (2)
Hospital Maria Middelares
Ghent, 9000, Belgium
Tero Rautio
Oulu, 90230, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 29, 2021
First Posted
January 19, 2022
Study Start
January 17, 2021
Primary Completion
October 30, 2021
Study Completion
December 21, 2021
Last Updated
January 19, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- After results are published without any time limitations
- Access Criteria
- When asked
All data is available for European Hernia Society researchers